Testing Doublebase Once Moisturizer for Atopic Eczema
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests a moisturizer called Doublebase Once for people with atopic eczema. You apply it once a day for 4 weeks to see how well it improves skin moisture and eczema symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have atopic eczema (personal or family history of eczema, asthma, or hay fever)
- Your eczema severity score (SCORAD) must be at least 15 at the start of the study
- You normally use a leave-on moisturizer regularly to manage your eczema
- You cannot be currently using antibiotics (by mouth or on the skin) or Doublebase Once
- You must be willing to use Doublebase Once as your only leave-on moisturizer once daily for 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new moisturizer called Doublebase Once, applied once daily, to see if it is safe and works well for people with ichthyosis. Participants will use the study moisturizer for one month instead of their usual one.
This study tests a new moisturizing product (RV4421B) for people with mild to moderate atopic dermatitis (eczema). Participants will use the product along with their usual steroid cream for 12 weeks to see how well it works and if it’s safe for different ages, from babies to adults.
This trial compares two moisturizers for people with eczema (moderate rash) and healthy volunteers. It looks at how well they work and how the skin tolerates them after using a steroid cream.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
This trial tests a new dermocosmetic cream for children with eczema. It looks at how well the cream works and how gentle it is on the skin, after the child uses a prescribed steroid cream to calm a flare-up.
This trial tests if two different moisturizing balms work equally well for treating mild to moderate eczema (atopic dermatitis) in children and adults. It may help find a more affordable or better-tolerated option.
Hear when a new Atopic Eczema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.